FIELD: biotechnology.
SUBSTANCE: group of inventions relates to biotechnology. Antibody or antigen binding fragment thereof for binding imiglucerase and an immunoaffinity chromatographic purification method of imiglucerase is provided. Antibody or its antigen-binding fragment comprises a combination of variable fragments of the heavy chain CDRH1, CDRH2, CDRH3 and light chain variable fragments CDRL1, CDRL2, CDRL3, corresponding to one of the following combinations: (i) SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6; (ii) SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12; (iii) SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18; (iv) SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24; (v) SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30; (vi) SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36; (vii) SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 42. Method of immunoaffinity chromatographic purification of imiglucerase involves applying to a chromatographic column with a carrier with immobilized antibodies and/or their antigen-binding fragments of the sample, containing imiglucerase, washing the column with buffer, elution of the adsorbed imiglucerase from the carrier in the presence of from 30 to 60 % ethylene glycol.
EFFECT: invention allows to obtain the preparation of active imiglucerase from the culture fluid in a single stage, which does not contain contaminants detected by polyacrylamide gel electrophoresis.
6 cl, 7 dwg, 8 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHODS AND COMPOSITIONS COMPRISING PURIFIED RECOMBINANT POLYPEPTIDES | 2014 |
|
RU2671481C2 |
METHOD OF MODIFICATION OF POLYPEPTIDE FOR PURIFICATION OF POLYPEPTIDE MULTIMERS | 2010 |
|
RU2606264C2 |
ANTIBODY TO IL-13RA2 AND ITS APPLICATION | 2018 |
|
RU2756623C2 |
MONOCLONAL ANTIBODIES TO HUMAN IL-17 AND THEIR APPLICATION | 2016 |
|
RU2663721C1 |
ANTIBODY AGAINST IL-4R AND APPLICATION THEREOF | 2018 |
|
RU2758091C1 |
TRI- OR TETRASPECIFIC ANTIBODIES | 2010 |
|
RU2570633C2 |
ANTI-CD47 ANTIBODIES AND METHODS FOR USE THEREOF | 2013 |
|
RU2693078C2 |
CYTOTOXICITY-INDUCING THERAPEUTIC AGENT | 2011 |
|
RU2663123C2 |
MONOCLONAL ANTIBODY TO IL-5RΑ | 2017 |
|
RU2698048C2 |
ANTIGEN ASSOCIATED WITH RHEUMATOID ARTHRITIS | 2013 |
|
RU2649368C2 |
Authors
Dates
2019-01-11—Published
2017-08-25—Filed